Loading...

Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity

This commentary provides the authors’ perspective on the article “Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial,” which has recently been published in The Lancet Oncology.

Na minha lista:
Bibliografiske detaljer
Main Authors: Madan, Ravi A, Heery, Christopher R., Gulley, James L.
Format: Artigo
Sprog:Inglês
Udgivet: Landes Bioscience 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494633/
https://ncbi.nlm.nih.gov/pubmed/23170267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20591
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!